

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.61629741 |
| 2 | cytidine deamination (GO:0009972) | 4.60954797 |
| 3 | cytidine metabolic process (GO:0046087) | 4.60954797 |
| 4 | cytidine catabolic process (GO:0006216) | 4.60954797 |
| 5 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.44791668 |
| 6 | cellular ketone body metabolic process (GO:0046950) | 4.31884291 |
| 7 | T cell migration (GO:0072678) | 4.25148536 |
| 8 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.19557852 |
| 9 | negative regulation by host of viral transcription (GO:0043922) | 4.14851204 |
| 10 | ketone body metabolic process (GO:1902224) | 3.94237017 |
| 11 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.83347598 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.83139311 |
| 13 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.82193097 |
| 14 | coenzyme catabolic process (GO:0009109) | 3.79474720 |
| 15 | regulation of chronic inflammatory response (GO:0002676) | 3.61808318 |
| 16 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.52825843 |
| 17 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.51472072 |
| 18 | regulation of B cell differentiation (GO:0045577) | 3.50195970 |
| 19 | lymphocyte chemotaxis (GO:0048247) | 3.49376026 |
| 20 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.45110287 |
| 21 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.44253768 |
| 22 | sperm motility (GO:0030317) | 3.43112875 |
| 23 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.42731600 |
| 24 | cellular response to interleukin-15 (GO:0071350) | 3.39872242 |
| 25 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.37957767 |
| 26 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.37957767 |
| 27 | NADH dehydrogenase complex assembly (GO:0010257) | 3.37957767 |
| 28 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.33602486 |
| 29 | cofactor catabolic process (GO:0051187) | 3.32502251 |
| 30 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.27091845 |
| 31 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.17406838 |
| 32 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.17387794 |
| 33 | actin nucleation (GO:0045010) | 3.10042459 |
| 34 | regulation of calcium-mediated signaling (GO:0050848) | 3.09175175 |
| 35 | macrophage chemotaxis (GO:0048246) | 3.06615227 |
| 36 | lymphocyte migration (GO:0072676) | 3.02947249 |
| 37 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.02075671 |
| 38 | response to interleukin-15 (GO:0070672) | 3.01842930 |
| 39 | multicellular organism reproduction (GO:0032504) | 2.99736739 |
| 40 | histone H4-K8 acetylation (GO:0043982) | 2.97060802 |
| 41 | histone H4-K5 acetylation (GO:0043981) | 2.97060802 |
| 42 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.96984607 |
| 43 | peptidyl-histidine modification (GO:0018202) | 2.93859862 |
| 44 | inner mitochondrial membrane organization (GO:0007007) | 2.92560548 |
| 45 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.91695148 |
| 46 | protein insertion into membrane (GO:0051205) | 2.89863780 |
| 47 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.89422424 |
| 48 | negative regulation of cell killing (GO:0031342) | 2.89422424 |
| 49 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.89255171 |
| 50 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.89255171 |
| 51 | chaperone-mediated protein transport (GO:0072321) | 2.88923829 |
| 52 | N-acetylneuraminate metabolic process (GO:0006054) | 2.87408973 |
| 53 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.87012459 |
| 54 | negative regulation of B cell mediated immunity (GO:0002713) | 2.87012459 |
| 55 | dendritic cell chemotaxis (GO:0002407) | 2.83145032 |
| 56 | response to interferon-beta (GO:0035456) | 2.82621583 |
| 57 | plasma membrane fusion (GO:0045026) | 2.79382999 |
| 58 | rRNA transcription (GO:0009303) | 2.77852773 |
| 59 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.76317242 |
| 60 | positive regulation of interleukin-2 production (GO:0032743) | 2.74480676 |
| 61 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.72787037 |
| 62 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.72384866 |
| 63 | Peyers patch development (GO:0048541) | 2.72384866 |
| 64 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.70650581 |
| 65 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.69405875 |
| 66 | negative regulation of viral genome replication (GO:0045071) | 2.65904050 |
| 67 | positive regulation of lymphocyte migration (GO:2000403) | 2.62792153 |
| 68 | dendritic cell migration (GO:0036336) | 2.62563494 |
| 69 | platelet dense granule organization (GO:0060155) | 2.61652531 |
| 70 | protein targeting to Golgi (GO:0000042) | 2.61197591 |
| 71 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.59893157 |
| 72 | inositol phosphate dephosphorylation (GO:0046855) | 2.59253378 |
| 73 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.59253378 |
| 74 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.58646486 |
| 75 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.58511975 |
| 76 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 2.58171238 |
| 77 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 2.58171238 |
| 78 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 2.58171238 |
| 79 | spliceosomal complex assembly (GO:0000245) | 2.57061679 |
| 80 | gamma-aminobutyric acid transport (GO:0015812) | 2.56898258 |
| 81 | inositol phosphate catabolic process (GO:0071545) | 2.56659869 |
| 82 | eosinophil chemotaxis (GO:0048245) | 2.55744325 |
| 83 | glycerophospholipid catabolic process (GO:0046475) | 2.55273633 |
| 84 | establishment of protein localization to Golgi (GO:0072600) | 2.55251026 |
| 85 | protein complex biogenesis (GO:0070271) | 2.53499774 |
| 86 | growth hormone secretion (GO:0030252) | 2.52903447 |
| 87 | negative regulation of viral transcription (GO:0032897) | 2.52801385 |
| 88 | adaptation of signaling pathway (GO:0023058) | 2.52597646 |
| 89 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.52546824 |
| 90 | negative regulation of membrane potential (GO:0045837) | 2.52515336 |
| 91 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.51522458 |
| 92 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.49943931 |
| 93 | cellular response to interferon-beta (GO:0035458) | 2.48970605 |
| 94 | protein-cofactor linkage (GO:0018065) | 2.48281916 |
| 95 | rRNA methylation (GO:0031167) | 2.45958218 |
| 96 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.45554602 |
| 97 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.45554602 |
| 98 | regulation of interleukin-2 production (GO:0032663) | 2.44127671 |
| 99 | negative regulation of T cell apoptotic process (GO:0070233) | 2.39746875 |
| 100 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.39069481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.22712256 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 6.14860585 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.42730564 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.42222608 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.14808349 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.05508183 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.37162869 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.32933464 |
| 9 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.17307293 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.13043384 |
| 11 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.08977579 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.92810059 |
| 13 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84650238 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.83986639 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.83014812 |
| 16 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.78302756 |
| 17 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.74996660 |
| 18 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.73525133 |
| 19 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.71398077 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66865947 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.66696450 |
| 22 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.63092447 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 1.61422830 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.57828140 |
| 25 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.55276028 |
| 26 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.54098482 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.53918689 |
| 28 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.53536546 |
| 29 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.49647194 |
| 30 | MAF_26560356_Chip-Seq_TH2_Human | 1.47809753 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.46604527 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.42520891 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.42353747 |
| 34 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.38014661 |
| 35 | SA1_27219007_Chip-Seq_Bcells_Human | 1.35782267 |
| 36 | GATA3_26560356_Chip-Seq_TH2_Human | 1.34589820 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.34231953 |
| 38 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.33406134 |
| 39 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.30318456 |
| 40 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.29964997 |
| 41 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.29832361 |
| 42 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.27673439 |
| 43 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.26984951 |
| 44 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.26963030 |
| 45 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.26787494 |
| 46 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.24303143 |
| 47 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.23239313 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23010577 |
| 49 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.21261149 |
| 50 | P68_20966046_ChIP-Seq_HELA_Human | 1.20587049 |
| 51 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.20440166 |
| 52 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.17871883 |
| 53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16571171 |
| 54 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.16220019 |
| 55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.16081997 |
| 56 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.15572319 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13139811 |
| 58 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.13119624 |
| 59 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.13119624 |
| 60 | P300_27268052_Chip-Seq_Bcells_Human | 1.10851142 |
| 61 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.10648636 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10617137 |
| 63 | AR_20517297_ChIP-Seq_VCAP_Human | 1.10543812 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.10527956 |
| 65 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.09764230 |
| 66 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.09708089 |
| 67 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05974898 |
| 68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05453537 |
| 69 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.05221562 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04934786 |
| 71 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.02584913 |
| 72 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.01787508 |
| 73 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01570515 |
| 74 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.01393468 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01187572 |
| 76 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.99511534 |
| 77 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.99471586 |
| 78 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.99184022 |
| 79 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98745056 |
| 80 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.98018252 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96429758 |
| 82 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.96327333 |
| 83 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.95533805 |
| 84 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95463406 |
| 85 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95308260 |
| 86 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.94130722 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93884923 |
| 88 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92207841 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90105844 |
| 90 | MAF_26560356_Chip-Seq_TH1_Human | 0.89961017 |
| 91 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.89632417 |
| 92 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88676250 |
| 93 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.88232817 |
| 94 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.88232817 |
| 95 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.87314945 |
| 96 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.87291168 |
| 97 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.87120456 |
| 98 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.86805473 |
| 99 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.86784748 |
| 100 | ERA_21632823_ChIP-Seq_H3396_Human | 0.86262079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002653_abnormal_ependyma_morphology | 4.34275206 |
| 2 | MP0005671_abnormal_response_to | 4.27615640 |
| 3 | MP0010386_abnormal_urinary_bladder | 3.34748953 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 2.57889291 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.52498880 |
| 6 | MP0009333_abnormal_splenocyte_physiolog | 2.51858954 |
| 7 | MP0004133_heterotaxia | 2.42446577 |
| 8 | MP0004043_abnormal_pH_regulation | 2.28630085 |
| 9 | MP0009785_altered_susceptibility_to | 2.28612541 |
| 10 | MP0005083_abnormal_biliary_tract | 2.26042785 |
| 11 | MP0004147_increased_porphyrin_level | 2.20416773 |
| 12 | MP0001501_abnormal_sleep_pattern | 2.15716472 |
| 13 | MP0003303_peritoneal_inflammation | 2.01163348 |
| 14 | MP0003172_abnormal_lysosome_physiology | 1.98614214 |
| 15 | MP0004742_abnormal_vestibular_system | 1.90409977 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 1.90377365 |
| 17 | MP0001800_abnormal_humoral_immune | 1.86702506 |
| 18 | MP0001790_abnormal_immune_system | 1.81857150 |
| 19 | MP0005387_immune_system_phenotype | 1.81857150 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.78554421 |
| 21 | MP0003183_abnormal_peptide_metabolism | 1.77620827 |
| 22 | MP0005645_abnormal_hypothalamus_physiol | 1.72351468 |
| 23 | MP0009745_abnormal_behavioral_response | 1.70859674 |
| 24 | MP0002095_abnormal_skin_pigmentation | 1.66299504 |
| 25 | MP0005410_abnormal_fertilization | 1.64060254 |
| 26 | MP0003436_decreased_susceptibility_to | 1.62298005 |
| 27 | MP0005379_endocrine/exocrine_gland_phen | 1.59539206 |
| 28 | MP0002723_abnormal_immune_serum | 1.58636155 |
| 29 | MP0005025_abnormal_response_to | 1.55894438 |
| 30 | MP0003045_fibrosis | 1.54181385 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.49254396 |
| 32 | MP0003866_abnormal_defecation | 1.46000268 |
| 33 | MP0001819_abnormal_immune_cell | 1.41543683 |
| 34 | MP0003786_premature_aging | 1.38917574 |
| 35 | MP0004233_abnormal_muscle_weight | 1.37557605 |
| 36 | MP0009379_abnormal_foot_pigmentation | 1.35251276 |
| 37 | MP0005551_abnormal_eye_electrophysiolog | 1.35079810 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.34252328 |
| 39 | MP0001986_abnormal_taste_sensitivity | 1.34068278 |
| 40 | MP0002405_respiratory_system_inflammati | 1.34062580 |
| 41 | MP0002139_abnormal_hepatobiliary_system | 1.33755728 |
| 42 | MP0005332_abnormal_amino_acid | 1.33215502 |
| 43 | MP0002064_seizures | 1.32499972 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.30598263 |
| 45 | MP0006082_CNS_inflammation | 1.28633995 |
| 46 | MP0003252_abnormal_bile_duct | 1.26724487 |
| 47 | MP0003763_abnormal_thymus_physiology | 1.25691829 |
| 48 | MP0009046_muscle_twitch | 1.24153765 |
| 49 | MP0002557_abnormal_social/conspecific_i | 1.23102072 |
| 50 | MP0000716_abnormal_immune_system | 1.23096859 |
| 51 | MP0002419_abnormal_innate_immunity | 1.22601212 |
| 52 | MP0002735_abnormal_chemical_nociception | 1.21445938 |
| 53 | MP0002398_abnormal_bone_marrow | 1.19378664 |
| 54 | MP0004142_abnormal_muscle_tone | 1.18862078 |
| 55 | MP0009697_abnormal_copulation | 1.18582189 |
| 56 | MP0002928_abnormal_bile_duct | 1.15975630 |
| 57 | MP0000371_diluted_coat_color | 1.15542429 |
| 58 | MP0000015_abnormal_ear_pigmentation | 1.14415550 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.14036882 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.13478712 |
| 61 | MP0008469_abnormal_protein_level | 1.12121531 |
| 62 | MP0006072_abnormal_retinal_apoptosis | 1.11040656 |
| 63 | MP0001486_abnormal_startle_reflex | 1.09282885 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 1.05477138 |
| 65 | MP0003186_abnormal_redox_activity | 1.03073748 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.01488410 |
| 67 | MP0002909_abnormal_adrenal_gland | 0.99804955 |
| 68 | MP0002163_abnormal_gland_morphology | 0.99774666 |
| 69 | MP0005636_abnormal_mineral_homeostasis | 0.99769411 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 0.97233418 |
| 71 | MP0005310_abnormal_salivary_gland | 0.96476470 |
| 72 | MP0002429_abnormal_blood_cell | 0.95539952 |
| 73 | MP0001765_abnormal_ion_homeostasis | 0.91972485 |
| 74 | MP0001905_abnormal_dopamine_level | 0.91732157 |
| 75 | MP0003698_abnormal_male_reproductive | 0.91699971 |
| 76 | MP0002229_neurodegeneration | 0.90620052 |
| 77 | MP0000604_amyloidosis | 0.86660550 |
| 78 | MP0000703_abnormal_thymus_morphology | 0.86168178 |
| 79 | MP0009643_abnormal_urine_homeostasis | 0.84164658 |
| 80 | MP0002722_abnormal_immune_system | 0.83333123 |
| 81 | MP0003329_amyloid_beta_deposits | 0.82341105 |
| 82 | MP0005365_abnormal_bile_salt | 0.80729933 |
| 83 | MP0008873_increased_physiological_sensi | 0.79805313 |
| 84 | MP0001853_heart_inflammation | 0.79792647 |
| 85 | MP0001502_abnormal_circadian_rhythm | 0.79131575 |
| 86 | MP0009763_increased_sensitivity_to | 0.78449606 |
| 87 | MP0000639_abnormal_adrenal_gland | 0.76640856 |
| 88 | MP0000538_abnormal_urinary_bladder | 0.75418654 |
| 89 | MP0005164_abnormal_response_to | 0.74930292 |
| 90 | MP0000685_abnormal_immune_system | 0.74669315 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.74146040 |
| 92 | MP0008007_abnormal_cellular_replicative | 0.72892241 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.70366702 |
| 94 | MP0002272_abnormal_nervous_system | 0.67915217 |
| 95 | MP0001929_abnormal_gametogenesis | 0.67576226 |
| 96 | MP0008872_abnormal_physiological_respon | 0.67457518 |
| 97 | MP0004924_abnormal_behavior | 0.66437799 |
| 98 | MP0005386_behavior/neurological_phenoty | 0.66437799 |
| 99 | MP0008874_decreased_physiological_sensi | 0.66081815 |
| 100 | MP0002733_abnormal_thermal_nociception | 0.63676121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Severe visual impairment (HP:0001141) | 5.04846674 |
| 2 | 3-Methylglutaconic aciduria (HP:0003535) | 4.90135288 |
| 3 | Abnormality of macular pigmentation (HP:0008002) | 3.94221251 |
| 4 | Aplastic anemia (HP:0001915) | 3.86373544 |
| 5 | Pendular nystagmus (HP:0012043) | 3.73814869 |
| 6 | T lymphocytopenia (HP:0005403) | 3.70436113 |
| 7 | Abnormality of T cell number (HP:0011839) | 3.63239004 |
| 8 | Bile duct proliferation (HP:0001408) | 3.48253899 |
| 9 | Abnormal biliary tract physiology (HP:0012439) | 3.48253899 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.34749154 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.24032794 |
| 12 | Abolished electroretinogram (ERG) (HP:0000550) | 3.10635490 |
| 13 | Hypoproteinemia (HP:0003075) | 3.08601514 |
| 14 | Encephalitis (HP:0002383) | 3.03339775 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 3.00590822 |
| 16 | Hemiplegia (HP:0002301) | 2.93290229 |
| 17 | Abnormality of the lower motor neuron (HP:0002366) | 2.88975853 |
| 18 | Autoimmune hemolytic anemia (HP:0001890) | 2.87784750 |
| 19 | Stomach cancer (HP:0012126) | 2.83721698 |
| 20 | Abnormality of T cells (HP:0002843) | 2.78877580 |
| 21 | Abnormality of DNA repair (HP:0003254) | 2.74831448 |
| 22 | Abnormality of alanine metabolism (HP:0010916) | 2.73884112 |
| 23 | Hyperalaninemia (HP:0003348) | 2.73884112 |
| 24 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.73884112 |
| 25 | Abnormality of macrophages (HP:0004311) | 2.69427110 |
| 26 | Acute hepatic failure (HP:0006554) | 2.65828366 |
| 27 | Retinal atrophy (HP:0001105) | 2.51172294 |
| 28 | Increased serum ferritin (HP:0003281) | 2.48902695 |
| 29 | Nephronophthisis (HP:0000090) | 2.46384900 |
| 30 | Polydipsia (HP:0001959) | 2.36195117 |
| 31 | Abnormal drinking behavior (HP:0030082) | 2.36195117 |
| 32 | Spastic tetraparesis (HP:0001285) | 2.35674872 |
| 33 | Albinism (HP:0001022) | 2.28922869 |
| 34 | Delayed CNS myelination (HP:0002188) | 2.22135682 |
| 35 | Agammaglobulinemia (HP:0004432) | 2.22094621 |
| 36 | Molar tooth sign on MRI (HP:0002419) | 2.21087969 |
| 37 | Abnormality of midbrain morphology (HP:0002418) | 2.21087969 |
| 38 | Increased serum pyruvate (HP:0003542) | 2.20973799 |
| 39 | Impulsivity (HP:0100710) | 2.14826763 |
| 40 | Recurrent fungal infections (HP:0002841) | 2.14824216 |
| 41 | Attenuation of retinal blood vessels (HP:0007843) | 2.14754643 |
| 42 | Poikiloderma (HP:0001029) | 2.14142409 |
| 43 | Thyroid-stimulating hormone excess (HP:0002925) | 2.14075870 |
| 44 | Meningitis (HP:0001287) | 2.13983683 |
| 45 | Hyponatremia (HP:0002902) | 2.12528252 |
| 46 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.12449406 |
| 47 | Hypoplasia of the brainstem (HP:0002365) | 2.12449406 |
| 48 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.10813929 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.09636345 |
| 50 | Congenital sensorineural hearing impairment (HP:0008527) | 2.09186670 |
| 51 | Abnormality of the renal medulla (HP:0100957) | 2.09070117 |
| 52 | Entropion (HP:0000621) | 2.08959372 |
| 53 | Increased IgM level (HP:0003496) | 2.08202119 |
| 54 | Medial flaring of the eyebrow (HP:0010747) | 2.07121353 |
| 55 | Diplopia (HP:0000651) | 2.06045351 |
| 56 | Abnormality of binocular vision (HP:0011514) | 2.06045351 |
| 57 | Decreased central vision (HP:0007663) | 2.05725615 |
| 58 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05347305 |
| 59 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05347305 |
| 60 | Cone-rod dystrophy (HP:0000548) | 2.05153278 |
| 61 | Pulmonary fibrosis (HP:0002206) | 2.04903739 |
| 62 | Gait imbalance (HP:0002141) | 2.04423814 |
| 63 | Recurrent viral infections (HP:0004429) | 2.03779027 |
| 64 | Recurrent sinusitis (HP:0011108) | 2.02932283 |
| 65 | Pancreatic fibrosis (HP:0100732) | 2.01738663 |
| 66 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98536124 |
| 67 | Abnormality of the renal cortex (HP:0011035) | 1.97919767 |
| 68 | Chronic hepatic failure (HP:0100626) | 1.93960523 |
| 69 | Myositis (HP:0100614) | 1.93684092 |
| 70 | Nephrogenic diabetes insipidus (HP:0009806) | 1.93181912 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 1.92594540 |
| 72 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.92494074 |
| 73 | Panhypogammaglobulinemia (HP:0003139) | 1.91554098 |
| 74 | Concave nail (HP:0001598) | 1.91428831 |
| 75 | Progressive visual loss (HP:0000529) | 1.90669743 |
| 76 | Hypokinesia (HP:0002375) | 1.87892321 |
| 77 | Acute necrotizing encephalopathy (HP:0006965) | 1.87040201 |
| 78 | Congenital primary aphakia (HP:0007707) | 1.86322823 |
| 79 | Polyuria (HP:0000103) | 1.85210311 |
| 80 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.84340653 |
| 81 | Abnormality of iron homeostasis (HP:0011031) | 1.84182606 |
| 82 | J-shaped sella turcica (HP:0002680) | 1.81150392 |
| 83 | Tetraplegia (HP:0002445) | 1.79814042 |
| 84 | Increased CSF lactate (HP:0002490) | 1.79245606 |
| 85 | Tongue fasciculations (HP:0001308) | 1.78762538 |
| 86 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.78717586 |
| 87 | Absent/shortened dynein arms (HP:0200106) | 1.78717586 |
| 88 | Chronic diarrhea (HP:0002028) | 1.78655961 |
| 89 | Epidermoid cyst (HP:0200040) | 1.77704484 |
| 90 | Abnormality of glycolysis (HP:0004366) | 1.77032569 |
| 91 | Nasal polyposis (HP:0100582) | 1.75531679 |
| 92 | Severe combined immunodeficiency (HP:0004430) | 1.74074166 |
| 93 | Abnormality of the motor neurons (HP:0002450) | 1.73871385 |
| 94 | Abnormal neuron morphology (HP:0012757) | 1.73871385 |
| 95 | Autoimmune thrombocytopenia (HP:0001973) | 1.71897092 |
| 96 | Pustule (HP:0200039) | 1.71886647 |
| 97 | Pancreatic cysts (HP:0001737) | 1.71175406 |
| 98 | Hypoplastic nipples (HP:0002557) | 1.70902364 |
| 99 | Recurrent bronchitis (HP:0002837) | 1.69309872 |
| 100 | Type II lissencephaly (HP:0007260) | 1.69251402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.95629015 |
| 2 | MAP4K2 | 4.12533887 |
| 3 | TXK | 3.48532453 |
| 4 | MAP4K1 | 3.34604966 |
| 5 | MAP3K4 | 2.96063879 |
| 6 | WNK4 | 2.38829936 |
| 7 | MAP3K12 | 2.35166030 |
| 8 | MUSK | 2.24971950 |
| 9 | IRAK4 | 2.10873872 |
| 10 | TESK1 | 2.09132140 |
| 11 | TESK2 | 2.00995266 |
| 12 | FES | 2.00362778 |
| 13 | ITK | 1.96063257 |
| 14 | RIPK4 | 1.94669735 |
| 15 | STK39 | 1.77299747 |
| 16 | PIK3CG | 1.76658491 |
| 17 | BCKDK | 1.59364608 |
| 18 | KDR | 1.49151785 |
| 19 | EIF2AK1 | 1.48066592 |
| 20 | MAPK15 | 1.47665589 |
| 21 | WNK3 | 1.43665877 |
| 22 | PAK6 | 1.40627256 |
| 23 | INSRR | 1.40021303 |
| 24 | MAP3K14 | 1.32816251 |
| 25 | BMPR2 | 1.29370563 |
| 26 | OXSR1 | 1.26183406 |
| 27 | PRKCQ | 1.19078528 |
| 28 | PLK4 | 1.15315880 |
| 29 | BRD4 | 1.10140285 |
| 30 | TLK1 | 1.09387199 |
| 31 | SYK | 1.08399475 |
| 32 | MARK1 | 1.08282421 |
| 33 | SCYL2 | 1.07317222 |
| 34 | KIT | 1.04445882 |
| 35 | PIK3CA | 1.01497577 |
| 36 | TRPM7 | 0.98881441 |
| 37 | ADRBK2 | 0.96288465 |
| 38 | TNK2 | 0.96126599 |
| 39 | MAPK13 | 0.93935012 |
| 40 | MAP2K7 | 0.90843625 |
| 41 | IKBKB | 0.90138916 |
| 42 | ERBB4 | 0.88675890 |
| 43 | MST4 | 0.87849769 |
| 44 | CAMKK2 | 0.86464182 |
| 45 | EPHA3 | 0.84617858 |
| 46 | MAP3K9 | 0.84236448 |
| 47 | MAP2K2 | 0.84148495 |
| 48 | MAP3K11 | 0.81825681 |
| 49 | ALK | 0.80970253 |
| 50 | CAMK1 | 0.80599436 |
| 51 | CSNK1G3 | 0.79952990 |
| 52 | BUB1 | 0.77694791 |
| 53 | ERN1 | 0.77374065 |
| 54 | TBK1 | 0.76805958 |
| 55 | EIF2AK3 | 0.75764322 |
| 56 | BLK | 0.74351765 |
| 57 | CAMK4 | 0.73113760 |
| 58 | CSNK1A1L | 0.71613707 |
| 59 | JAK2 | 0.71012701 |
| 60 | CSF1R | 0.70685266 |
| 61 | TAOK1 | 0.70354676 |
| 62 | DYRK2 | 0.70027730 |
| 63 | MYLK | 0.69368654 |
| 64 | BMX | 0.69065763 |
| 65 | LCK | 0.66980778 |
| 66 | PINK1 | 0.66841232 |
| 67 | GRK1 | 0.66812498 |
| 68 | GRK7 | 0.65970787 |
| 69 | MATK | 0.65898697 |
| 70 | ERBB3 | 0.65875209 |
| 71 | NME2 | 0.62703984 |
| 72 | EPHB1 | 0.62681770 |
| 73 | ADRBK1 | 0.59415645 |
| 74 | SIK2 | 0.57604823 |
| 75 | IKBKE | 0.57175497 |
| 76 | HCK | 0.56757652 |
| 77 | PDK1 | 0.56198588 |
| 78 | CSNK1G2 | 0.55599703 |
| 79 | CDK3 | 0.54960137 |
| 80 | MAPK12 | 0.54691903 |
| 81 | LYN | 0.52489875 |
| 82 | JAK3 | 0.51297917 |
| 83 | VRK2 | 0.50503983 |
| 84 | TYK2 | 0.48039787 |
| 85 | OBSCN | 0.47228007 |
| 86 | MARK3 | 0.46247165 |
| 87 | DAPK1 | 0.46106547 |
| 88 | BCR | 0.46072484 |
| 89 | SIK3 | 0.45862541 |
| 90 | ZAP70 | 0.44626212 |
| 91 | DAPK2 | 0.44385411 |
| 92 | CSK | 0.44243056 |
| 93 | BTK | 0.42032037 |
| 94 | MAP3K1 | 0.40440809 |
| 95 | MAP2K1 | 0.38244882 |
| 96 | NTRK2 | 0.38055000 |
| 97 | IRAK3 | 0.37270642 |
| 98 | PKN1 | 0.35511308 |
| 99 | PAK3 | 0.35086808 |
| 100 | MAPK11 | 0.34915270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.96214386 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.54199167 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.90594723 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.69962944 |
| 5 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.67714189 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.65960155 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.45659236 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.17007095 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.16440423 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.13957353 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.13150781 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.11984321 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.99330065 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.90002762 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.82424767 |
| 16 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.79038015 |
| 17 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.74280079 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.70201206 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.66551376 |
| 20 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.63641639 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.62391912 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.59286988 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.56080250 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.52904331 |
| 25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.52024958 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49002023 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.43329823 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.39124320 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.32817195 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.31639248 |
| 31 | Proteasome_Homo sapiens_hsa03050 | 1.31108225 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.29783712 |
| 33 | Phototransduction_Homo sapiens_hsa04744 | 1.27204439 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.26634538 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23668096 |
| 36 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.19147634 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18860886 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.18162679 |
| 39 | Taste transduction_Homo sapiens_hsa04742 | 1.17845751 |
| 40 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.17353354 |
| 41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15026543 |
| 42 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.09879376 |
| 43 | RNA polymerase_Homo sapiens_hsa03020 | 1.07406615 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06934575 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06117999 |
| 46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.04445516 |
| 47 | Nicotine addiction_Homo sapiens_hsa05033 | 0.93073166 |
| 48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92922967 |
| 49 | Olfactory transduction_Homo sapiens_hsa04740 | 0.92890305 |
| 50 | Measles_Homo sapiens_hsa05162 | 0.92095056 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77625142 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 0.77217992 |
| 53 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.75570556 |
| 54 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.74759191 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 0.74258119 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71067923 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67213517 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65487793 |
| 59 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63920111 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.63432482 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59609539 |
| 62 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59243985 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57925196 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53065507 |
| 65 | Basal transcription factors_Homo sapiens_hsa03022 | 0.52990452 |
| 66 | Morphine addiction_Homo sapiens_hsa05032 | 0.50939190 |
| 67 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.50558034 |
| 68 | Asthma_Homo sapiens_hsa05310 | 0.50034307 |
| 69 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.48327085 |
| 70 | Long-term depression_Homo sapiens_hsa04730 | 0.46624326 |
| 71 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46562792 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45873574 |
| 73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.45305189 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44849210 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43889156 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42621733 |
| 77 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41036770 |
| 78 | Ribosome_Homo sapiens_hsa03010 | 0.39708344 |
| 79 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39660906 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39193676 |
| 81 | Circadian entrainment_Homo sapiens_hsa04713 | 0.38004715 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.37975563 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37553069 |
| 84 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.35842129 |
| 85 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.35668178 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31816384 |
| 87 | Leishmaniasis_Homo sapiens_hsa05140 | 0.31524857 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31243137 |
| 89 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.31149046 |
| 90 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31060585 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.30651878 |
| 92 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.30439244 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29765359 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.29237997 |
| 95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.26976708 |
| 96 | Tuberculosis_Homo sapiens_hsa05152 | 0.26960390 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.26788327 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.26134971 |
| 99 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.26065968 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26022673 |

